Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Macleods Pharmaceuticals Ltd
Location
T. Score
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
People
Network
Registered Details

MACLEODS PHARMACEUTICALS LTD

www.macleodspharma.com

Active

Updated: 02 Nov 2024

The company manufactures pharmaceutical products for various therapeutic diseases

Macleods Pharmaceuticals Ltd, is an unlisted public company incorporated on 05 June, 1989. It is classified as a public limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 65.00 cr and the total paid-up capital is INR 64.87 cr.

Industry

Manufacturing of Pharmaceuticals

Products

coated, and enteric coated tablets; hard and soft gelatin capsules, bi-layered, uncoated, dispersible

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales

6.65%

₹ 8,333.2

EBITDA

46.3%

₹ 2,094.0

Net Profit

38.69%

₹ 2,046.2

Networth

29.59%

₹ 8,941.9

Borrowings

69.93%

₹ 216.3

Assets

22.79%

₹ 10,677.5

Gross Margin

3.14

65.8 %

Operating Margin

6.81

25.1 %

Net Profit Margin

4.68

23.1 %

Return on Equity

1.5

22.9 %

ROCE

8.37

32.1 %

Debt to Equity

0.0

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

View subscriptions and buy credits

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (55)

State	Type	Address

Locations on Map

Tofler Score

Excellent

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Financial Highlights

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	6,589.9	7,174.2	7,462.7	7,813.3	8,333.2
Operating profit	1,903.7	2,408.3	1,559.0	1,431.3	2,094.0
Net profit	1,855.2	2,164.1	1,167.2	1,475.4	2,046.2
Gross margin	66.8	69.1	62.4	62.6	65.8
Operating margin	28.9	33.6	20.9	18.3	25.1
Net margin	26.8	27.9	15.4	18.4	23.1
Networth	8,092.7	10,293.6	5,413.3	6,900.2	8,941.9
Borrowings	-	113.1	78.1	127.3	216.3
Assets	9,396.3	11,700.6	6,975.9	8,695.7	10,677.5
Debt to equity	0.0	0.0	0.0	0.0	0.0
Current ratio	4.4	7.6	2.7	3.3	4.0
ROE	22.9	21.0	21.6	21.4	22.9
Days payable	115.0	86.0	70.0	74.0	60.0
WC days	199.0	339.0	108.0	162.0	178.0

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	20.0	20.0	59.9	59.9	64.9
Reserves	8,072.7	10,273.6	5,353.4	6,840.3	8,877.0
Borrowings +	-	113.1	78.1	127.3	216.3
Long term borrowings	-	33.4	-	-	-
Short term borrowings	-	79.7	78.1	127.3	216.3
Trade payables +	690.0	522.9	536.7	592.3	467.4
Days payable	115.0	86.0	70.0	74.0	60.0
Other liabilities +	1,303.6	1,293.9	1,484.5	1,668.2	1,519.3
Other non-current liabilities	255.2	369.8	237.8	258.3	400.4
Other current liabilities	358.3	401.1	710.1	817.6	651.4
Total liabilities	9,396.3	11,700.6	6,975.9	8,695.7	10,677.5
Fixed Assets +	1,486.2	1,888.0	1,833.9	1,834.6	1,940.2
Tangible assets	1,266.6	1,617.9	1,495.0	1,637.6	1,598.0
CWIP	213.6	264.4	334.3	189.9	287.4
Intangible assets	6.0	5.7	4.5	7.1	54.8
LT loans and advances	16.0	9.9	9.0	31.9	24.9
Other non-current assets	3,259.8	2,135.7	1,597.3	1,818.4	3,309.9
Current assets +	4,634.3	7,667.0	3,535.7	5,010.8	5,402.5
Inventories	895.9	1,155.2	1,542.7	1,239.2	1,412.1
Trade receivables	1,199.0	1,645.0	1,260.0	1,126.3	1,234.0
Cash and cash equivalents	282.0	155.0	17.8	47.1	33.7
ST loans and advances	0.4	0.4	0.3	0.5	0.6
Other current assets	2,256.9	4,711.4	715.0	2,597.7	2,722.1
Total assets	9,396.3	11,700.6	6,975.9	8,695.7	10,677.5

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	0.21	0.17	0.86	0.69	0.61
Reserves	85.91	87.8	76.74	78.66	83.14
Borrowings +	0.0	0.97	1.12	1.46	2.03
Long term borrowings	0.0	0.29	0.0	0.0	0.0
Short term borrowings	0.0	0.68	1.12	1.46	2.03
Trade payables	7.34	4.47	7.69	6.81	4.38
Other liabilities +	13.87	11.06	21.28	19.18	14.23
Other non-current liabilities	2.72	3.16	3.41	2.97	3.75
Other current liabilities	3.81	3.43	10.18	9.4	6.1
Total liabilities
Fixed Assets +	15.82	16.14	26.29	21.1	18.17
Tangible assets	13.48	13.83	21.43	18.83	14.97
CWIP	2.27	2.26	4.79	2.18	2.69
Intangible assets	0.06	0.05	0.07	0.08	0.51
LT loans and advances	0.17	0.08	0.13	0.37	0.23
Other non-current assets	34.69	18.25	22.9	20.91	31.0
Current assets +	49.32	65.53	50.68	57.62	50.6
Inventories	9.54	9.87	22.11	14.25	13.23
Trade receivables	12.76	14.06	18.06	12.95	11.56
Cash and cash equivalents	3.0	1.33	0.25	0.54	0.32
ST loans and advances	0.0	0.0	0.0	0.01	0.01
Other current assets	24.02	40.27	10.25	29.87	25.49
Total assets

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	20.0	20.0	59.9	59.9	64.9
Reserves	8,065.2	9,945.5	4,973.2	6,640.9	8,658.2
Borrowings +	-	113.1	78.1	127.3	225.1
Long term borrowings	-	33.4	-	-	8.8
Short term borrowings	-	79.7	78.1	127.3	216.3
Trade payables +	769.9	667.4	653.5	660.4	542.4
Days payable	114.0	98.0	78.0	80.0	69.0
Other liabilities +	1,373.0	1,349.1	1,966.7	2,064.9	1,983.3
Other non-current liabilities	239.4	275.9	240.3	260.1	401.4
Other current liabilities	363.8	405.9	1,072.9	1,144.4	1,039.4
Total liabilities	9,458.2	11,427.8	7,078.0	8,893.0	10,931.4
Fixed Assets +	1,500.6	1,904.0	1,845.0	1,841.6	1,962.4
Tangible assets	1,277.8	1,631.0	1,506.2	1,644.5	1,650.9
CWIP	213.6	264.4	334.3	189.9	287.4
Intangible assets	9.3	8.5	4.5	7.2	24.1
LT loans and advances	0.4	0.2	0.7	0.4	0.5
Other non-current assets	3,263.7	2,180.2	1,633.9	1,838.7	3,333.3
Current assets +	4,693.5	7,343.4	3,598.3	5,212.2	5,635.2
Inventories	952.0	1,422.5	1,713.7	1,366.8	1,582.0
Trade receivables	1,132.1	996.9	1,097.2	1,115.2	1,225.9
Cash and cash equivalents	356.1	199.4	67.6	128.2	100.0
ST loans and advances	0.4	0.4	0.3	0.5	0.6
Other current assets	2,252.9	4,724.1	719.5	2,601.5	2,726.8
Total assets	9,458.2	11,427.8	7,078.0	8,893.0	10,931.4

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	0.21	0.17	0.85	0.67	0.59
Reserves	85.27	87.03	70.26	74.68	79.2
Borrowings +	0.0	0.99	1.1	1.43	2.06
Long term borrowings	0.0	0.29	0.0	0.0	0.08
Short term borrowings	0.0	0.7	1.1	1.43	1.98
Trade payables	8.14	5.84	9.23	7.43	4.96
Other liabilities +	14.52	11.81	27.79	23.22	18.14
Other non-current liabilities	2.53	2.41	3.4	2.92	3.67
Other current liabilities	3.85	3.55	15.16	12.87	9.51
Total liabilities
Fixed Assets +	15.87	16.66	26.07	20.71	17.95
Tangible assets	13.51	14.27	21.28	18.49	15.1
CWIP	2.26	2.31	4.72	2.14	2.63
Intangible assets	0.1	0.07	0.06	0.08	0.22
LT loans and advances	0.0	0.0	0.01	0.0	0.0
Other non-current assets	34.51	19.08	23.08	20.68	30.49
Current assets +	49.62	64.26	50.84	58.61	51.55
Inventories	10.07	12.45	24.21	15.37	14.47
Trade receivables	11.97	8.72	15.5	12.54	11.21
Cash and cash equivalents	3.76	1.74	0.95	1.44	0.91
ST loans and advances	0.0	0.0	0.0	0.01	0.01
Other current assets	23.82	41.34	10.17	29.25	24.94
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	6,589.9	7,174.2	7,462.7	7,813.3	8,333.2
Sales growth %	8.45	8.87	4.02	4.7	6.65
Expenses +	4,799.3	4,898.0	6,071.0	6,559.3	6,414.6
Cost of goods	2,187.9	2,218.0	2,806.1	2,919.5	2,852.1
Employee cost	981.9	1,247.3	1,497.5	1,578.1	1,651.2
Other costs	1,516.3	1,300.5	1,600.1	1,884.3	1,735.9
Operating profit +	1,903.7	2,408.3	1,559.0	1,431.3	2,094.0
Operating margin %	28.9	33.6	20.9	18.3	25.1
Other income	330.0	587.7	126.2	213.3	539.0
Interest	18.6	24.7	10.8	7.4	11.6
Depreciation	94.6	107.4	156.6	169.9	163.9
Exceptional items	-	-	-	-	-
Profit before tax	2,120.5	2,863.9	1,517.8	1,467.4	2,457.5
Tax	265.3	699.8	350.6	-8.0	411.3
Profit - disc. ops	-	-	-	-	-
Net profit	1,855.2	2,164.1	1,167.2	1,475.4	2,046.2
Net margin %	26.8	27.9	15.4	18.4	23.1

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	95.23	92.43	98.34	97.34	93.92
Expenses +	69.36	63.1	80.0	81.72	72.3
Cost of goods	31.62	28.58	36.98	36.37	32.15
Employee cost	14.19	16.07	19.73	19.66	18.61
Other costs	21.91	16.76	21.08	23.48	19.57
Operating profit	27.51	31.03	20.54	17.83	23.6
Other income	4.77	7.57	1.66	2.66	6.08
Interest	0.27	0.32	0.14	0.09	0.13
Depreciation	1.37	1.38	2.06	2.12	1.85
Exceptional items	0.0	0.0	0.0	0.0	0.0
Profit before tax	30.64	36.9	20.0	18.28	27.7
Tax	3.83	9.02	4.62	-0.1	4.64
Profit - disc. ops	0.0	0.0	0.0	0.0	0.0
Net profit	26.81	27.88	15.38	18.38	23.06

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	7,268.4	7,312.0	8,207.1	8,171.6	8,667.8
Sales growth %	16.62	0.6	12.24	-0.43	6.07
Expenses +	5,301.2	5,461.8	6,556.3	6,693.2	6,763.5
Cost of goods	2,470.6	2,474.4	3,062.1	3,018.3	2,889.5
Employee cost	1,017.8	1,285.6	1,541.1	1,625.3	1,712.0
Other costs	1,696.3	1,566.8	1,781.9	1,868.9	1,983.6
Operating profit +	2,083.7	1,985.2	1,821.9	1,659.2	2,082.6
Operating margin %	28.7	27.1	22.2	20.3	24.0
Other income	326.5	590.6	49.1	200.0	528.7
Interest	18.7	25.1	11.4	7.8	11.7
Depreciation	97.7	109.9	159.8	172.9	166.7
Exceptional items	-	-	-72.1	-	-
Profit before tax	2,293.7	2,440.8	1,627.9	1,678.4	2,432.9
Tax	273.9	588.7	299.6	13.5	415.9
Profit - disc. ops	-	-	-99.1	-	-
Net profit	2,019.8	1,852.2	1,229.5	1,666.5	2,021.3
Net margin %	26.6	23.4	15.1	19.9	22.0

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	95.7	92.53	99.4	97.61	94.25
Expenses +	69.8	69.11	79.41	79.95	73.54
Cost of goods	32.53	31.31	37.09	36.05	31.42
Employee cost	13.4	16.27	18.67	19.41	18.62
Other costs	22.33	19.83	21.58	22.32	21.57
Operating profit	27.44	25.12	22.07	19.82	22.65
Other income	4.3	7.47	0.6	2.39	5.75
Interest	0.25	0.32	0.14	0.09	0.13
Depreciation	1.29	1.39	1.94	2.07	1.81
Exceptional items	0.0	0.0	-0.87	0.0	0.0
Profit before tax	30.2	30.89	19.72	20.05	26.46
Tax	3.61	7.45	3.63	0.16	4.52
Profit - disc. ops	0.0	0.0	-1.2	0.0	0.0
Net profit	26.59	23.44	14.89	19.91	21.98

Revenue from operations

Ratios

Standalone

Consolidated

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	0.0	0.0	0.0	0.0	0.0
Net Debt/Equity	0.0	0.0	0.0	0.0	0.0
Total Debt/Assets	0.0	0.0	0.0	0.0	0.0
Total Assets/Equity	1.2	1.1	1.3	1.3	1.2
Liquidity +
Current Ratio	4.4	7.6	2.7	3.3	4.0
Quick Ratio	3.6	6.5	1.5	2.5	3.0
Interest Coverage	102.5	97.5	144.2	192.6	180.3
Performance
Gross Margin	66.8	69.1	62.4	62.6	65.8
Operating Margin	28.9	33.6	20.9	18.3	25.1
Net Margin	26.8	27.9	15.4	18.4	23.1
Return +
Return on Equity	22.9	21.0	21.6	21.4	22.9
Pre-tax ROCE	35.7	26.9	34.7	23.8	32.1
Return on Assets	19.7	18.5	16.7	17.0	19.2
Pre-tax ROIC	22.4	22.4	25.6	18.1	21.1
Efficiency +
Days Payable	115.0	86.0	70.0	74.0	60.0
Days Inventory	149.0	190.0	201.0	155.0	181.0
Days Receivable	66.0	84.0	62.0	53.0	54.0
Fixed Asset Turnover	4.4	3.8	4.1	4.3	4.3
Total Asset Turnover	0.7	0.6	1.1	0.9	0.8
Working Capital
Cash Conversion Cycle	100.0	188.0	193.0	134.0	175.0
Working Capital Days	199.0	339.0	108.0	162.0	178.0

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	0.0	0.0	0.0	0.0	0.0
Net Debt/Equity	0.0	0.0	0.0	0.0	0.0
Total Debt/Assets	0.0	0.0	0.0	0.0	0.0
Total Assets/Equity	1.2	1.1	1.4	1.3	1.2
Liquidity +
Current Ratio	4.1	6.4	2.0	2.7	3.1
Quick Ratio	3.3	5.1	1.0	2.0	2.2
Interest Coverage	111.2	79.0	160.3	213.4	178.0
Performance
Gross Margin	66.0	66.2	62.7	63.1	66.7
Operating Margin	28.7	27.1	22.2	20.3	24.0
Net Margin	26.6	23.4	15.1	19.9	22.0
Return +
Return on Equity	25.0	18.6	24.4	24.9	23.2
Pre-tax ROCE	39.2	23.2	45.7	29.0	33.0
Return on Assets	21.4	16.2	17.4	18.7	18.5
Pre-tax ROIC	24.6	18.8	33.0	22.2	21.6
Efficiency +
Days Payable	114.0	98.0	78.0	80.0	69.0
Days Inventory	141.0	210.0	204.0	165.0	200.0
Days Receivable	57.0	50.0	49.0	50.0	52.0
Fixed Asset Turnover	4.8	3.8	4.5	4.4	4.4
Total Asset Turnover	0.8	0.6	1.2	0.9	0.8
Working Capital
Cash Conversion Cycle	84.0	162.0	175.0	135.0	183.0
Working Capital Days	179.0	309.0	80.0	147.0	162.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

Bank wise

Charges

State Bank of India

No. of Loans: 1

Total Amount : 299.7 cr

Standard Chartered Bank

No. of Loans: 1

Total Amount : 71.5 cr

HDFC Bank Limited

No. of Loans: 1

Total Amount : 59.9 cr

Axis Bank Limited

No. of Loans: 1

Total Amount : 50.0 cr

Charge Holder	Amount	Date of creation/modification
State Bank of India	299.7 cr	07 Dec, 2021
Standard Chartered Bank	71.5 cr	31 Jul, 2021
HDFC Bank Limited	59.9 cr	21 Jun, 2021
Axis Bank Limited	50.0 cr	26 Apr, 2021

Charges

State Bank of India

Standard Chartered Bank

HDFC Bank Limited

Axis Bank Limited

People

Designation	Name	DIN/PAN	Tenure
Managing Director	Banwarilal Murlidhar Bawri Shareholder	00017795	36 years
Director	Girdharilal Murlidhar Bawri Shareholder	00034197	35 years
Managing Director	Rajendra Murlidhar Agarwal Shareholder	00034224	36 years
Director	Vinita Mayur Danait	00216529	3 years
Director	Mihir Bipin Shah	07586469	9 years
Director	Arvind Sadashiv Mokashi	09305967	3 years
CEO	Vijay Girdharilal Agarwal Shareholder	<HIDDEN>	3 years
CS	Siddhesh Mahadeo Rane	<HIDDEN>	6 years

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
EAST AND WEST CLOTHING PRIVATE LIMITED	Active	15.0 L	2	Maharashtra
AGARWAL HOLDINGS PRIVATE LIMITED	Active	20.0 Cr	4	Maharashtra
MACLEODS LABORATORIES PRIVATE LIMITED	Active	1.2 L	2	Maharashtra
KALYANKRIT INDUSTRIES PRIVATE LIMITED	Active	50.0 L	3	Maharashtra
AGARWAL HOLDINGS PRIVATE LIMITED	Active	20.0 Cr	4	Maharashtra
RATNIDEVI MURLIDHAR BAWRI SOCIAL WELFARE FOUNDATION	Active	1.0 L	2	Maharashtra
KAN CONSULTANCY SOLUTIONS PRIVATE LIMITED	Strike Off	7.5 L	1	Maharashtra
PMEA SOLAR SYSTEMS PRIVATE LIMITED	Active	10.5 Cr	1	Maharashtra
INDIA DEBT RESOLUTION COMPANY LIMITED	Active	20.0 Cr	1	Maharashtra
CREDIT WISE CAPITAL PRIVATE LIMITED	Active	76.2 Cr	1	Maharashtra
SURYA LAKSHMI COTTON MILLS LTD	Active	25.8 Cr	1	Telangana
TERRACIS DIGITAL LIMITED	Active	11.2 Cr	1	Maharashtra

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
Macleods Pharma Espana S L U, Spain	Spain	-	-
Macleods Pharmaceuticals, LLC, Ukraine	Ukraine	-	-
Macleods Pharmaceuticals SA (Pty.) Ltd., South Africa	South Africa	-	-
Macleods Pharma USA INC., USA	United States	-	-
Macleods Pharma UK Ltd., UK	United Kingdom	-	-
Makmed LLC	Russian Federation	-	-
Oxus Pharma Ltd	Nigeria	-	-
Macleods Pharmaceuticals Philippines,inc	Philippines	-	-
Macleods Pharmaceuticals SDN BHD	Malaysia	-	-
Macleods Pharmaceuticals Philippines inc	Philippines	-	-

Registered Details

CIN

U24239MH1989PLC052049

PAN

AAACM4100C

Incorporation

1989, 35.8 years

Company Email

roc@macleodspharma.com

Paid up Capital

₹ 64.9 Cr

Authorised Capital

₹ 65.0 Cr

AGM

Sep 2023

Type

Public

Non-government Company

FAQ - MACLEODS PHARMACEUTICALS LTD

What is the incorporation date of MACLEODS PHARMACEUTICALS LTD?

The incorporation date of MACLEODS PHARMACEUTICALS LTD is 05 June, 1989

What is the authorized share capital of MACLEODS PHARMACEUTICALS LTD?

The authorized share capital of MACLEODS PHARMACEUTICALS LTD is INR ₹ 65.0 Cr.

What is the paid-up capital of MACLEODS PHARMACEUTICALS LTD?

The paid-up capital of MACLEODS PHARMACEUTICALS LTD is INR ₹ 64.9 Cr.

What is the registered address of MACLEODS PHARMACEUTICALS LTD?

The registered address of MACLEODS PHARMACEUTICALS LTD is 304, ATLANTA ARCADE, MAROL CHURCH ROAD, ANDHERI (EAST) NA MUMBAI Maharashtra - 400059

What is the CIN number of MACLEODS PHARMACEUTICALS LTD?

The CIN number of MACLEODS PHARMACEUTICALS LTD is U24239MH1989PLC052049.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

MACLEODS PHARMACEUTICALS LTD

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Industry

Buy Report or Plans

Dashboards

Company dashboard

View subscriptions and buy credits

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

Tofler Score

Risk

About Tofler Score

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Charges

People

Company Network